Mark Bodenrader's most recent trade in Cerevel Therapeutics Holdings Inc was a trade of 24,852 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 19, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cerevel Therapeutics Holdi... | Bodenrader Mark | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 24,852 | 24,852 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdi... | Mark Bodenrader | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 14,199 | 0 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdi... | Mark Bodenrader | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 14,199 | 20,528 | - | - | Common Stock | |
| Cerevel Therapeutics Holdi... | Bodenrader Mark | See Remarks | Sale of securities on an exchange or to another person at price $ 41.42 per share. | 19 Dec 2023 | 7,889 | 17,724 | - | 41.4 | 326,788 | Common Stock |
| Cerevel Therapeutics Holdi... | Bodenrader Mark | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 5,085 | 25,613 | - | - | Common Stock | |
| Cerevel Therapeutics Holdi... | Mark Bodenrader | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 5,085 | 0 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdi... | Mark Bodenrader | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,733 | 7,417 | - | - | Common Stock | |
| Cerevel Therapeutics Holdi... | Mark Bodenrader | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,733 | 14,199 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdi... | Mark Bodenrader | See Remarks | Sale of securities on an exchange or to another person at price $ 32.95 per share. | 01 Jun 2023 | 1,895 | 5,522 | - | 32.9 | 62,440 | Common Stock |
| Cerevel Therapeutics Holdi... | Mark Bodenrader | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 20,012 | 20,012 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Mark Bodenrader | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 5,085 | 5,085 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdi... | Mark Bodenrader | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 18,932 | 18,932 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdi... | Mark Bodenrader | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Mark Bodenrader | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2020 | 65,445 | 65,445 | - | - | Stock Option (Right to Buy) |